Dr. Jack S. Remington Laboratory
The Remington Lab for Specialty Diagnostics, a leader in toxoplasmosis research for over 50 years, develops innovative diagnostic tests.
The Remington Lab has been dedicated solely to the laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis for over 50 years.
If your doctor suspects you may be infected with toxoplasmosis, they may send a sample to the Dr. Jack S. Remington Laboratory for Specialty Diagnostics, formerly known as the Toxoplasma Serology Laboratory, for testing. The lab runs a number of proprietary tests to diagnose toxoplasmosis in patients referred by their healthcare provider.
Doctors at the laboratory also offer interpretation of test results and consult with clinicians worldwide on treatment and patient management. The lab’s tests on the blood of pregnant women with positive IgM antibodies — a sign of Toxoplasmosis — reported by other laboratories has helped rule out false positives and reduced medically unnecessary abortions by 50%.
This facility serves as the reference laboratory for the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), and have worked with these agencies to disseminate information to medical professionals and the public about toxoplasmosis and its diagnosis.
Additional Resources
For Clinicians
Our comprehensive guide provides in-depth information on laboratory tests and the latest diagnostic techniques. Learn about serological tests, PCR and histological methods. Our team at the Remington Lab offers confirmatory testing and consultation to help you make informed decisions.
For Patients
Learn essential tips and advice from experts at the Remington Lab to safeguard your pregnancy and prevent serious complications for your child.
Test Menu and Information
The Toxoplasma Serology Lab Test Menu and Information is provided for physicians and medical professionals to read about the current guidelines for the tests listed.
Contact Us
Email remingtonlab@sutterhealth.org or call 650-853-4828.
Below are available forms for ordering tests from the lab.
- Testing in Pregnant Women (PDF)
- Testing in Newborns and Infants (1 year of age or younger) (PDF)
- Testing in Non-Pregnant Adults and Older Children (Older than 1 year of age) (PDF)
- Immunocompromised Patient (PDF
- Complete List of Specimen Requirements and Testing Information/Forms (PDF
- Covid-19 Specimen Requirements and Testing Information (PDF)
Billing Information
Our laboratory will process your patient's specimen only if proper billing information is provided on billing portion of the requisition. Testing will not be performed until billing information is provided.
We cannot bill insurance or the patient directly. We can only bill the hospital, doctor or laboratory where specimen originated. Another option is for the patient to include a personal check or money order along with the specimen. These latter patients will receive a paid receipt after testing is completed. Please be aware that, if your patient's check does not clear or if there is a remaining balance, the ordering physician is responsible for all charges.
The Dr. Jack S. Remington Laboratory for Specialty Diagnostics is a not-for-profit laboratory.
New York Physicians
New York State law prohibits us from billing New York State physicians directly. Therefore, all patients whose specimens are sent to us by a private physician must include a check or money order. Specimens will only be held for two weeks if proper payment is not provided.
Payment Terms
Payment terms are net 30 days. Past due accounts may be subject to collections by an agency of the Palo Alto Medical Foundation. Please make checks payable to the Dr. Jack S. Remington Laboratory for Specialty Diagnostics.
In order to ensure that your account is properly credited, the invoice number must be included and the address for remittance must include all of the following information:
Dr. Jack S. Remington Laboratory for Specialty Diagnostics
795 El Camino Real, Ames Building
Palo Alto, CA 94301
Discount Pricing Policy
Panels (see Test Menu and Information or Fee Schedule):
- IgG/IgM Toxo Panel
- Toxoplasma Pregnancy Panel (16 weeks gestation or earlier)
- Toxoplasma Pregnancy Panel (more than 16 weeks gestation)
- Toxoplasma Infant Panel (less than 6 months of age)
- Toxoplasma Panel (6 months of age or older)
All testing performed that would fit into any panel will be charged the discounted price while a patient's case is still open. For urgent cases, we will attempt to contact client for authorization for further confirmatory testing (recommended by consulting physicians) twice via fax. If we do not receive authorization after two faxes, the results will be reported as final and the patient's case will be closed. Once a final report has been generated, the client will be charged the full amount for each additional test.
Insurance Reimbursement
Our laboratory is not a contracted provider for any health insurance carriers. We cannot directly bill any insurance company for our charges. We provide the following information to assist in submitting charges for reimbursement from insurance carriers:
CPT Codes
CPT codes are listed in our invoice, Fee Schedule and Test Menu and Information
Toxoplasma ICD-10 Codes
- Toxoplasmosis (acquired) — B58.9
- With pneumonia — B58.3
- Congenital, active — P37.1
- With other organ involvement — B58.89
- Maternal
- Protozoal diseases complicating pregnancy, first trimester – O98.611
- Protozoal diseases complicating pregnancy, second trimester – O98.612
- Protozoal diseases complicating pregnancy, third trimester – O98.613
- Protozoal diseases complicating pregnancy, unspecified trimester – O98.619Protozoal diseases complicating childbirth – O98.62
- Protozoal diseases complicating the puerperium – O98.63
Newborn suspected to be affected by other maternal infectious and parasitic diseases (code to be used on the newborn record only) – P00.2
Covid ICD-10 codes
- Encounter for screening for COVID-19—Z11.52
- Contact with and (suspected) exposure to COVID-19—Z20.822
- Coronavirus infection, unspecified—B34.2
- Personal history of COVID-19—Z86.16
- Post COVID-19 condition, unspecified—U09.9
- Pneumonia due to coronavirus disease 2019—J12.82
Tax ID Number
94-1156581
Fee Schedule
Find information below about our fees and billing information.
(Effective 1/1/2023)
Individual Tests | Prices / CPT codes |
---|---|
IgG (Dye Test) | $180 / 86777 |
Alternative IgG | $180 / 86777 |
Remington IgM ELISA (6 months of age or older) | $185 / 86778 |
Alternative IgM (6 months of age or older) | $185 / 86778 |
Remington IgM ISAGA (less than 6 months of age) | $185 / 86778 |
Remington IgA ELISA | $180 / 86777-59 |
AC/HS | $196 / 86406 (2 units) |
Remington IgE ELISA (Offered only as part of a panel and not as a single test) | $175 / 86777-59 |
Avidity (For clinical recommendations IgG (Dye test) and IgM ELISA are required) See: Toxoplasma Pregnancy Panel (16 weeks gestation or earlier) | $196 / 86777-59 |
Toxoplasma PCR (amniotic fluid, cerebrospinal fluid, vitreous fluid, urine, whole blood, other body fluids) | $465 / 87798 |
Toxoplasma PCR (solid tissues) | $485 / 87798 |
Isolation | $677 / 87003 |
Covid IgG | $140 / 86318 |
Covid PCR | $155 / 87635 |
Panels | |
IgG/IgM Toxo Panel Includes: IgG (Dye Test), Remington IgM ELISA or Alternative IgG, Alternative IgM | $350 / 86777, 86778 |
Toxoplasma Pregnancy Panel (16 weeks gestation or earlier) Includes: IgG (Dye Test), Remington IgM ELISA, Avidity | $546 / 86777, 86778, 86777-59 |
Toxoplasma Pregnancy Panel (more than 16 weeks gestation) Includes: IgG (Dye Test), Remington IgM ELISA, AC/HS, Avidity | $742 / 86777, 86778, 86406 (2 units), 86777-59 |
Toxoplasma Infant Panel (less than 6 months of age) Includes: IgG (Dye Test), Remington IgM ISAGA, Remington IgA ELISA | $515 / 86777, 86778, 86777-59 |
Toxoplasma Panel (6 months of age or older) Includes: IgG (Dye Test), Remington IgM ELISA, Remington IgA ELISA, Remington IgE ELISA, AC/HS | $876 / 86777, 86778, 86777-59, 86777-59, 86406 (2 units) |
PCR Fee Schedule
(Effective 1/1/2023)
Test - Prices / CPT codes
- Toxoplasma PCR (amniotic fluid, cerebrospinal fluid, vitreous fluid, urine, whole blood, other body fluids) - $465 / 87798
- Toxoplasma PCR (solid tissues) - $485 / 87798
- Covid PCR - $155 / 87635
Test Information
Toxoplasma PCR
- Reference range: reported as "Toxoplasma gondii DNA detected," "Toxoplasma gondii DNA not detected," or indeterminate
- Specimen: (refer to PCR Specimen Requirements table)
- Volume: (refer to PCR Specimen Requirements table)
- Transport temperature: (refer to PCR Specimen Requirements table)
- CPT code: 87798
- Fee: $465 - $485
Method References
- Grover C, Thulliez P, Remington J, Boothroyd J. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol 28:2297-2301, 1990.
- Parmley S, Goebel F, Remington JS. Detection of Toxoplasma gondii in cerebro-spinal fluid from AIDS patients by polymerase chain reaction. J Clin Microbiol 30:3000-3002, 1992
COVID-19 PCR
- Reference range: reported as negative or positive
- Specimen: (refer to PCR Specimen Requirements table)
- Volume: (refer to PCR Specimen Requirements table)
- Transport temperature: (refer to PCR Specimen Requirements table)
- CPT code: 87635
- Fee: $155
Method References
- TaqPath™ COVID-19 Combo Kit INSTRUCTIONS FOR USE, Catalog Number A47814 Publication Number MAN0019181 Revision G.0
Testing Schedule
Toxoplasma PCR: Specimens received by 12:00 pm (Pacific Time) on Tuesday will have verbal results available Wednesday by 3:00 pm (Pacific Time). Specimens received by 12:00 pm (Pacific Time) on Friday will have verbal results available Monday by 3:00 pm (Pacific Time).
COVID-19 PCR: Specimens received by noon Monday-Friday (Pacific Time) will be tested same day. Results are available within 48 hours.
Business Hours
7:00 am – 3:00 pm (Pacific Time)
Monday – Friday
Note: To ensure the quality of results, repeat testing is sometimes required. This may delay reporting of results.
Download a copy of our license by choosing the agency name below.
Agency - License/Permit Numbers
- CLIA (PDF): 05D0643684
- California (PDF): Lab ID: CLF 00003619
- Maryland (PDF): 803
- New York (PDF): PFI: 4927 CLIA: 05D0643684
- Pennsylvania (PDF): Lab ID: 27937A
- Rhode Island (PDF): License: LCO00342
Bibliography of the Remington Laboratory
The following is a list of articles, books and book chapters published by the physicians and medical staff of the lab. Most links are to abstracts of those articles.
COVID-19 publications up to 04/05/2021
- Liu T, Hsiung J, Zhao S, Kost J, Sreedhar D, Hanson CV, Olson K, Keare D, Chang ST, Bliden KP, Gurbel PA, Tantry US, Roche J, Press C, Boggs J, Rodriguez-Soto JP, Montoya JG, Tang M, Dai H.Liu T, et al. Among authors: montoya jg. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng. 2020 Dec;4(12):1188-1196. doi: 10.1038/s41551-020-00642-4. Epub 2020 Oct 29.Nat Biomed Eng. 2020. PMID: 33122853
- Gharamti AA, Mei F, Jankousky KC, Huang J, Hyson P, Chastain DB, Fan J, Osae S, Zhang WW, Montoya JG, Erlandson KM, Scherger SJ, Franco-Paredes C, Henao-Martínez AF, Shapiro L.Gharamti AA, et al. Among authors: montoya jg. Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study. medRxiv. 2020 Oct 22:2020.10.20.20216309. doi: 10.1101/2020.10.20.20216309. Preprint.medRxiv. 2020. PMID: 33106821
TOXOPLASMOSIS publications up to 04/05/2021
- Khan A, Schwenk HT, Kohlman K, Bertaina A, Cho S, Montoya JG, Contopoulos-Ioannidis D.Khan A, et al. Among authors: montoya jg. Response to Trimethoprim-Sulfamethoxazole in a Pediatric Hematopoietic Stem Cell Transplant Recipient With Disseminated Toxoplasmosis: A Case Report. J Pediatric Infect Dis Soc. 2021 Mar 6:piab006. doi: 10.1093/jpids/piab006. Online ahead of print.J Pediatric Infect Dis Soc. 2021. PMID: 33693793
- Contopoulos-Ioannidis DG, Cho SM, Bertaina A, Leung AN, Fischbein N, Lanzman B, Schwenk HT, Montoya JG.Contopoulos-Ioannidis DG, et al. Among authors: montoya jg. Toxoplasmosis Among 38,751 Hematopoietic Stem Cell Transplant Recipients: A Systematic Review of Disease Prevalence and a Compilation of Imaging and Autopsy Findings. Transplantation. 2021 Feb 4. doi: 10.1097/TP.0000000000003662. Online ahead of print.Transplantation. 2021. PMID: 33654004
- Guegan H, Stajner T, Bobic B, Press C, Olariu RT, Olson K, Srbljanovic J, Montoya JG, Djurković-Djaković O, Robert-Gangneux F.Guegan H, et al. Among authors: montoya jg. Maternal Anti-Toxoplasma Treatment during Pregnancy Is Associated with Reduced Sensitivity of Diagnostic Tests for Congenital Infection in the Neonate. J Clin Microbiol. 2021 Jan 21;59(2):e01368-20. doi: 10.1128/JCM.01368-20. Print 2021 Jan 21.J Clin Microbiol. 2021. PMID: 33208476
- Schumacher AC, Elbadawi LI, DeSalvo T, Straily A, Ajzenberg D, Letzer D, Moldenhauer E, Handly TL, Hill D, Dardé ML, Pomares C, Passebosc-Faure K, Bisgard K, Gomez CA, Press C, Smiley S, Montoya JG, Kazmierczak JJ.Schumacher AC, et al. Among authors: montoya jg. Toxoplasmosis Outbreak Associated With Toxoplasma gondii-Contaminated Venison-High Attack Rate, Unusual Clinical Presentation, and Atypical Genotype. Clin Infect Dis. 2020 May 15:ciaa285. doi: 10.1093/cid/ciaa285. Online ahead of print.Clin Infect Dis. 2020. PMID: 32412062
- Vera CN, Linam WM, Gadde JA, Wolf DS, Walson K, Montoya JG, Rostad CA.Vera CN, et al. Among authors: montoya jg. Congenital Toxoplasmosis Presenting as Eosinophilic Encephalomyelitis With Spinal Cord Hemorrhage. Pediatrics. 2020 Feb;145(2):e20191425. doi: 10.1542/peds.2019-1425. Epub 2020 Jan 15.Pediatrics. 2020. PMID: 31941759 Free article.
- Pomares C, Estran R, Press CJ, Bera A, Ramirez R, Montoya JG, Robert Gangneux F.Pomares C, et al. Among authors: montoya jg. Is Real-Time PCR Targeting Rep 529 Suitable for Diagnosis of Toxoplasmosis in Patients Infected with Non-Type II Strains in North America? J Clin Microbiol. 2020 Jan 28;58(2):e01223-19. doi: 10.1128/JCM.01223-19. Print 2020 Jan 28.J Clin Microbiol. 2020. PMID: 31694976 Free PMC article.
- Cortés JA, Roncancio Á, Uribe LG, Cortés-Luna CF, Montoya JG.Cortés JA, et al. Among authors: montoya jg. Approach to ocular toxoplasmosis including pregnant women. Curr Opin Infect Dis. 2019 Oct;32(5):426-434. doi: 10.1097/QCO.0000000000000577.Curr Opin Infect Dis. 2019. PMID: 31313714
- Montoya JG, Multani A.Montoya JG, et al. Curr Editorial: Diagnosis of infection in immunocompromised patients: from microscopy to next generation sequencing and host gene signatures. Opin Infect Dis. 2019 Aug;32(4):295-299. doi: 10.1097/QCO.0000000000000567.Curr Opin Infect Dis. 2019. PMID: 31169551
Articles
- Blackburn B, Montoya JG. “Parasitic Infections in Transplant Patients: Toxoplasmosis, Strongyloidiasis, and Other Parasites”. In: Safdar, A, ed. Principles and Practice of Transplant Infectious Diseases
- Contopoulos D., Montoya, JG. “Toxoplasma gondii Infection an Toxoplasmosis” Principles and Practice of Pediatric Infectious Diseases . Fifth Edition. Elsevier Saunders
- Montoya J.G. Toxoplasmosis. In: Goldman L and Schafer AI, eds. Goldman’s Cecil Medicine. 25th Edition. Philadelphia: Elsevier Saunders
- Montoya JG, Boothroyd J, Kovacs J. “Toxoplasma gondii”. In: Bennett J.E., Dolin R. and Blaser, MJ, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Pages 3122-3153. Eight Edition. Elsevier Churchill Livingstone 2019
- Montoya J.G. Toxoplasmosis. In: Goldman L and Schafer AI, eds. Goldman’s Cecil Medicine. 26th Edition -2017. Philadelphia: Elsevier Saunders
- Montoya JG, Gomez CA. “Toxoplasmosis in Solid Organ Transplant Patients”. In: Bowden RA, Ljungman P, and Snydman DR, eds. Transplant Infections. Philadelphia: Lippincott Williams & Wilkins, Fourth Edition 2016.
- Montoya JG, Boothroyd J, Kovacs J. “Toxoplasma gondii”. In: Bennett J.E., Dolin R. and Blaser, MJ, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Pages 3122-3153. Eight Edition. Elsevier Churchill Livingstone 2015
- Montoya JG, Boyer, K. “Toxoplasma gondii Infections”, In: Section 3, Summaries of Infectious Diseases; 2015 Red Book; Associate Editor: D. Kimberlin.
- Montoya JG. “Toxoplasma gondii and Toxoplasmosis”. In: Infections of the Central Nervous System, 4th edition. Michael Scheld, Richard Whitley, and Christina Marra, Editors. Philadelphia: Wolters Kluwer Health, 2014
- Contopoulos D., Montoya, JG. “Toxoplasma gondii Infection an Toxoplasmosis” Principles and Practice of Pediatric Infectious Diseases . Fourth Edition. Elsevier Saunders. pp. 1308-1307, 2012.
- Moncada P, Montoya. JG. “Toxoplasma gondii and Toxoplasmosis. In: Volberding PA, Greene WC, Lange JMA, Gallant JE, Sewankambo N, editors. Sande’s HIV/AIDS Medicine: Medical Management of AIDS 2013. Second Edition. Elsevier Saunders. pp. 397-410, 2012.
- Montoya, JG, Boyer, K. American Academy of Pediatrics. “Toxoplasma gondii Infections (Toxoplasmosis)”. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th Edition. Pages 720-728. Elk Grove Village, IL: American Academy of Pediatrics; 2012
- Montoya J.G. Toxoplasmosis. In: Goldman L and Schafer AI, eds. Goldman’s Cecil Medicine. 24th Edition. Philadelphia: Elsevier Saunders, pp. 2030-2038, 2012.
- Blackburn B, Montoya JG. “Parasitic Infections in Cancer Patients: Toxoplasmosis, Strongyloidiasis, and Other Parasites”. In: Safdar, A, ed. Principles and Practice of Cancer Infectious Diseases. First Edition. New York: Humana Press, 2011.
- Montoya JG, Lunn MR. “Toxoplasmosis in Solid Organ Transplant Patients”. In: Bowden RA, Ljungman P, and Snydman DR, eds. Transplant Infections. Third Edition. Philadelphia: Lippincott Williams & Wilkins, 2010.
- Montoya JG, Boothroyd J, Kovacs J. “Toxoplasma gondii”. In: Mandell G, Dolin A, Bennett J, eds. Principles and Practice of Infectious Diseases. Seventh Edition. Elsevier Churchill Livingstone. pp. 3495-3526; 2010.
- McLeod, R., Remington, J. S.: Toxoplasmosis (Toxoplasma gondii) In: Nelson Textbook of Pediatrics, 18th Edition, Behrman, R.E., Kliegman, R.M., Jenson, H., eds. Philadelphia: W. B. Saunders Company, 1486-95, 2007.
- Montoya, J., Kovacs, J., and Remington, J.: Toxoplasmosis; In Principles and Practice of Infectious Diseases; 6th Edition, Mandell, G., Bennett, J. and Dolin R. (eds); Churchill Livingstone; Vol. 2, pp 3170-3198, 2005
- Montoya, J., Kovacs, J., and Remington, J.: Toxoplasmosis; In Principles and Practice of Infectious Diseases; 6th Edition, Mandell, G., Bennett, J. and Dolin R. (eds); Churchill Livingstone; Vol. 2, pp 3170-3198, 2005
- McLeod, R. Remington, J. S.: Toxoplasmosis In Infectious Diseases, 3rd Edition;. S.L. Gorbach, J.G. Bartlett, N.R. Blacklow, eds., Philadelphia: The W. B. Saunders Company, pp. 1508-29, 2004.
- Liesenfeld, O., and Remington, J.S.: Toxoplasmosis. In Infectious Diseases in Women, First Edition. S. Faro and D.E. Soper, eds. Philadelphia: W.B. Saunders Company, pp. 57-79, 2001.
- Montoya, J.G, Remington, J. S. “Toxoplasma gondii”. In: Mandell G., Dolin, A., and Bennett, J., (eds). Principles and Practice of Infectious Diseases. Pgs 2858-88. Fifth Edition. 2000.
Books and Book Chapters
- Blackburn B, Montoya JG. “Parasitic Infections in Transplant Patients: Toxoplasmosis, Strongyloidiasis, and Other Parasites”. In: Safdar, A, ed. Principles and Practice of Transplant Infectious Diseases
- Contopoulos D., Montoya, JG. “Toxoplasma gondii Infection an Toxoplasmosis” Principles and Practice of Pediatric Infectious Diseases . Fifth Edition. Elsevier Saunders
- Montoya J.G. Toxoplasmosis. In: Goldman L and Schafer AI, eds. Goldman’s Cecil Medicine. 25th Edition. Philadelphia: Elsevier Saunders
- Montoya JG, Boothroyd J, Kovacs J. “Toxoplasma gondii”. In: Bennett J.E., Dolin R. and Blaser, MJ, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Pages 3122-3153. Eight Edition. Elsevier Churchill Livingstone 2019
- Montoya J.G. Toxoplasmosis. In: Goldman L and Schafer AI, eds. Goldman’s Cecil Medicine. 26th Edition -2017. Philadelphia: Elsevier Saunders
- Montoya JG, Gomez CA. “Toxoplasmosis in Solid Organ Transplant Patients”. In: Bowden RA, Ljungman P, and Snydman DR, eds. Transplant Infections. Philadelphia: Lippincott Williams & Wilkins, Fourth Edition 2016.
- Montoya JG, Boothroyd J, Kovacs J. “Toxoplasma gondii”. In: Bennett J.E., Dolin R. and Blaser, MJ, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Pages 3122-3153. Eight Edition. Elsevier Churchill Livingstone 2015
- Montoya JG, Boyer, K. “Toxoplasma gondii Infections”, In: Section 3, Summaries of Infectious Diseases; 2015 Red Book; Associate Editor: D. Kimberlin.
- Montoya JG. “Toxoplasma gondii and Toxoplasmosis”. In: Infections of the Central Nervous System, 4th edition. Michael Scheld, Richard Whitley, and Christina Marra, Editors. Philadelphia: Wolters Kluwer Health, 2014
- Contopoulos D., Montoya, JG. “Toxoplasma gondii Infection an Toxoplasmosis” Principles and Practice of Pediatric Infectious Diseases . Fourth Edition. Elsevier Saunders. pp. 1308-1307, 2012.
- Moncada P, Montoya. JG. “Toxoplasma gondii and Toxoplasmosis. In: Volberding PA, Greene WC, Lange JMA, Gallant JE, Sewankambo N, editors. Sande’s HIV/AIDS Medicine: Medical Management of AIDS 2013. Second Edition. Elsevier Saunders. pp. 397-410, 2012.
- Montoya, JG, Boyer, K. American Academy of Pediatrics. “Toxoplasma gondii Infections (Toxoplasmosis)”. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th Edition. Pages 720-728. Elk Grove Village, IL: American Academy of Pediatrics; 2012
- Montoya J.G. Toxoplasmosis. In: Goldman L and Schafer AI, eds. Goldman’s Cecil Medicine. 24th Edition. Philadelphia: Elsevier Saunders, pp. 2030-2038, 2012.
- Blackburn B, Montoya JG. “Parasitic Infections in Cancer Patients: Toxoplasmosis, Strongyloidiasis, and Other Parasites”. In: Safdar, A, ed. Principles and Practice of Cancer Infectious Diseases. First Edition. New York: Humana Press, 2011.
- Montoya JG, Lunn MR. “Toxoplasmosis in Solid Organ Transplant Patients”. In: Bowden RA, Ljungman P, and Snydman DR, eds. Transplant Infections. Third Edition. Philadelphia: Lippincott Williams & Wilkins, 2010.
- Montoya JG, Boothroyd J, Kovacs J. “Toxoplasma gondii”. In: Mandell G, Dolin A, Bennett J, eds. Principles and Practice of Infectious Diseases. Seventh Edition. Elsevier Churchill Livingstone. pp. 3495-3526; 2010.
- McLeod, R., Remington, J. S.: Toxoplasmosis (Toxoplasma gondii) In: Nelson Textbook of Pediatrics, 18th Edition, Behrman, R.E., Kliegman, R.M., Jenson, H., eds. Philadelphia: W. B. Saunders Company, 1486-95, 2007.
- Montoya, J., Kovacs, J., and Remington, J.: Toxoplasmosis; In Principles and Practice of Infectious Diseases; 6th Edition, Mandell, G., Bennett, J. and Dolin R. (eds); Churchill Livingstone; Vol. 2, pp 3170-3198, 2005
- Montoya, J., Kovacs, J., and Remington, J.: Toxoplasmosis; In Principles and Practice of Infectious Diseases; 6th Edition, Mandell, G., Bennett, J. and Dolin R. (eds); Churchill Livingstone; Vol. 2, pp 3170-3198, 2005
- McLeod, R. Remington, J. S.: Toxoplasmosis In Infectious Diseases, 3rd Edition;. S.L. Gorbach, J.G. Bartlett, N.R. Blacklow, eds., Philadelphia: The W. B. Saunders Company, pp. 1508-29, 2004.
- Liesenfeld, O., and Remington, J.S.: Toxoplasmosis. In Infectious Diseases in Women, First Edition. S. Faro and D.E. Soper, eds. Philadelphia: W.B. Saunders Company, pp. 57-79, 2001.
- Montoya, J.G, Remington, J. S. “Toxoplasma gondii”. In: Mandell G., Dolin, A., and Bennett, J., (eds). Principles and Practice of Infectious Diseases. Pgs 2858-88. Fifth Edition. 2000.